Status:
COMPLETED
Typing of Human Papilloma Virus (HPV) From Female Genital Warts
Lead Sponsor:
University of Cape Town
Collaborating Sponsors:
Merck Sharp & Dohme LLC
Conditions:
Genital Warts
Human Papilloma Virus
Eligibility:
FEMALE
Brief Summary
This is a longitudinal observational study of women presenting to Groote Schuur Hospital with genital warts. The study will evaluate the socio-demographic characteristics of the women using a structur...
Detailed Description
Genital Human Papillomavirus (HPV) infection is the most common sexually transmitted viral disease in the world.1,2 HPV infection on genital epithelia is associated with a range of disease spectra, fr...
Eligibility Criteria
Inclusion
- All female patients with genital warts
Exclusion
- Patients who are pregnant, too frail or ill for gynaeoclogical examination and refusal to participate
Key Trial Info
Start Date :
April 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2012
Estimated Enrollment :
156 Patients enrolled
Trial Details
Trial ID
NCT01192282
Start Date
April 1 2010
End Date
August 1 2012
Last Update
January 24 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groote Schuur Hospital
Cape Town, Western Cape, South Africa, 7925